Figure and Table | Real-world Evidence for the Treatment of Rosacea with Sulfur or Metronidazole Preparation in Japanese Patients

Table 1. Comparison of Patients’ Profiles between TSP and TMP before the Intervention.

	Topical treatment
Parameters	TSP	TMP	p-value
Age (years)	46.2 ± 21.3	48.1 ± 11.9	0.469
Sex (number of patients)			0.237
Male	3	1
Female	19	24
Type of rosacea (number of patients)			0.861
ETR	10	12
PPR	12	13
Results of Demodex exam. (number of patients)			0.632
Positive	18	20
Negative	4	4
Not examined	0	1
IGA score (number of patients)			0.600
2	5	9
3	9	9
4	8	7
VAS score (mean value ± standard deviation)
Itch	50.2 ± 31.4	37.2 ± 25.7	0.094
Burning sensation	24.5 ± 28.8	29.1 ± 26.2	0.303
Flushing	27.1 ± 27.6	28.1 ± 27.5	0.839
Hypersensitivity	50.4 ± 29.9	54.6 ± 28.9	0.654
IGA score (mean value ± standard deviation)	3.14 ± 0.77	2.92 ± 0.81	0.353

Table 2. Comparison of Outcomes between TSP and TMP.

	Topical treatment
Parameters	TSP	TMP	p-value
Results of Demodex exam. (number of patients)			0.212
Positive	6	8
Negative	15	12
Not examined	1	5
Adverse events (number of patients)			0.215
Absent	13	19
Present	9	6